The global prevalence of multidrug-resistance among Acinetobacter baumannii causing hospital-acquired and ventilator-associated pneumonia and its associated mortality: A systematic review and meta-analysis
Hospital-acquired pneumonia (HAP) is a lung infection that develops after more than 48 hours of hospitalization, and, if associated with mechanical ventilation, it is termed ventilator-associated pneumonia (VAP).1 They are the second most common nosocomial infections and are important causes of morbidity and mortality around the world.2,3 These nosocomial pneumonias increase duration of hospitalization and healthcare costs. A matched case-control study demonstrated that having VAP prolonged duration of mechanical ventilation, intensive care unit (ICU) stay and hospitalization.
Source: Journal of Infection - Category: Infectious Diseases Authors: Lim S Mohd Sazlly, A Zainal Abidin, SM Liew, JA Roberts, FB Sime Tags: Review Source Type: research
More News: Acinetobacter | Healthcare Costs | Hospitals | Infectious Diseases | Intensive Care | Multidrug Resistance | Pneumonia | Study